Similar fungal gut microbiota found in MG patients, healthy adults: Study
Composition of the fungal species present in the gut — known as the fungal gut microbiota — does not differ…
Andrea Lobo is a Science writer at Bionews since 2022. She holds a PhD in Cell Biology/Neurosciences, where she studied the molecular pathways that contribute to neurodegeneration/neuroprotection in stroke biology. Between 2011 and 2021, she worked as a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, focused on the molecular mechanisms involved in drug addiction, particularly neuronal plasticity and remodeling induced by amphetamines. As a research scientist for 19 years, Andrea also participated in academic projects in other research fields, including gene regulation, cancer, and rare diseases. During her professional journey, Andrea also developed her science writing skills by writing/editing scientific papers and grant proposals.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Composition of the fungal species present in the gut — known as the fungal gut microbiota — does not differ…
Ad Scientiam has launched a program to develop and validate new digital biomarkers for self-assessing patients with generalized…
Thymus removal surgery is generally safe for the majority of elderly people who have myasthenia gravis (MG), a study…
Post-operative myasthenic crisis is a dangerous complication after thymus removal surgery for people with myasthenia gravis (MG) who had…
A protein called CD59 might protect the neuromuscular junction — the place where nerve cells come into contact and communicate…
The presence of anti-titin antibodies, a type of blood protein, in patients with thymoma-associated myasthenia gravis (MG) is…
Intravenous immunoglobulin therapy was not effective at reducing the daily dose of corticosteroids for treating myasthenia gravis (MG),…
Get regular updates to your inbox.